# US 2006/0154269 A1 · Cleavage of nucleic acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154269 A1
- Document ID: US20060154269A1
- Status: Published application
- Kind: A1
- Application number: 11/182,336
- Filed: 2005-07-15
- Published: 2006-07-13
- Earliest claimed: 1996-01-24
- Inventors: James Prudent; Jeff Hall; Victor Lyamichev; Mary Ann Brow; James Dahlberg
- Web page: https://patentgrep.com/patent/US20060154269A1

## CPC

- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12Q 1/6823: Release of bound markers
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/683: involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
- Y10S 435/81: Packaged device or kit
- Y10S 435/822: using bacteria or actinomycetales
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The present invention relates to means for the detection and characterization of nucleic acid sequences, as well as variations in nucleic acid sequences. The present invention also relates to methods for forming a nucleic acid cleavage structure on a target sequence and cleaving the nucleic acid cleavage structure in a site-specific manner. The structure-specific nuclease activity of a variety of enzymes is used to cleave the target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations thereof.

## Claims

### Claim at position 1

1-25. (canceled)

### Claim 26

A composition comprising a purified thermostable FEN-1 endonuclease and a purified nucleic acid molecule.

### Claim 27 (depends on 26)

The composition of claim 26, wherein said thermostable FEN-1 endonuclease comprises a FEN-1 endonuclease from an archaebacterial species.

### Claim 28 (depends on 27)

The composition of claim 27, wherein said FEN-1 endonuclease comprises a FEN-1 endonuclease from Pyrococcus furiosus.

### Claim 29 (depends on 26)

The composition of claim 26, wherein said FEN-1 endonuclease comprises the sequence SEQ ID NO:115.

### Claim 30 (depends on 27)

The composition of claim 27, wherein said FEN-1 endonuclease comprises a FEN-1 endonuclease from Methanococcus jannaschii.

### Claim 31 (depends on 26)

The composition of claim 26, wherein said FEN-1 endonuclease comprises the sequence SEQ ID NO: 111.

### Claim 32 (depends on 26)

The composition of claim 26, wherein said thermostable FEN-1 endonuclease comprises a non-natural thermostable FEN-1 endonuclease.

### Claim 33 (depends on 26)

The composition of claim 26, further comprising a polymerase.

### Claim 34 (depends on 33)

The composition of claim 33, wherein said polymerase comprises a thermostable polymerase.

### Claim 35 (depends on 33)

The composition of claim 33, wherein said polymerase comprises a template-independent polymerase.

### Claim 36 (depends on 33)

The composition of claim 33, wherein said polymerase comprises a template-dependent polymerase.

### Claim 37 (depends on 26)

The composition of claim 26, wherein said purified thermostable FEN-1 endonuclease and said purified nucleic acid molecule are in a mixture.

### Claim 38 (depends on 26)

The composition of claim 26, wherein said nucleic acid molecule comprises a probe oligonucleotide.

### Claim 39 (depends on 26)

The composition of claim 26, further comprising a buffer comprising magnesium.

### Claim 40 (depends on 26)

The composition of claim 26, further comprising a labeled molecule.

### Claim 41 (depends on 26)

The composition of claim 26, wherein said nucleic acid molecule comprises a label.

### Claim 42 (depends on 41)

The composition of claim 41, wherein said label comprises a fluorescent label.

### Claim 43 (depends on 26)

The composition of claim 26, further a second nucleic acid molecule.

### Claim 44 (depends on 43)

The composition of claim 43, wherein said purified nucleic acid and said second nucleic acid molecule are capable of hybridizing to a target nucleic acid having a first region and a second region, said second region downstream of and contiguous to said first region, wherein at least a portion of said purified nucleic acid molecule is completely complementary to said first region of said target nucleic acid and wherein said second nucleic acid molecule comprises a 3′ portion and a 5′ portion, wherein said 5′ portion is completely complementary to said second region of said target nucleic acid.

### Claim 45 (depends on 44)

The composition of claim 44, further comprising a stacker oligonucleotide.
